Pharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Gabapentin, and what substitute generic drugs are available?

Gabapentin is a drug marketed by Sciegen Pharms Inc, Alkem Labs Ltd, Acella Pharms Llc, Invagen Pharms, Ranbaxy, Sun Pharm Inds Ltd, Marksans Pharma, Teva Pharms Usa, Ivax Sub Teva Pharms, Sandoz, Amneal Pharms, Zydus Pharms Usa Inc, Teva, Amneal Pharms Ny, Teva Pharms, Mylan Pharms Inc, Sun Pharm Inds, Aci Healthcare Ltd, Actavis Elizabeth, Hikma, Aurobindo Pharma Ltd, Alkem, Mylan, Apotex Inc, Taro, Glenmark Generics, Hi Tech Pharma, Hikma Pharms, Watson Labs, and Tris Pharma Inc. and is included in forty-three NDAs.

The generic ingredient in GABAPENTIN is gabapentin. There are twenty-six drug master file entries for this compound. One hundred and two suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the gabapentin profile page.

Summary for Tradename: GABAPENTIN

Suppliers / Packagers: see list99
Bulk Api Vendors: see list93
Clinical Trials: see list102
Patent Applications: see list6,333
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:GABAPENTIN at DailyMed

Pharmacology for Tradename: GABAPENTIN

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
CAPSULE;ORAL077261-001Aug 2, 2013RXNoNo► Subscribe► Subscribe
Actavis Elizabeth
TABLET;ORAL075694-002Oct 21, 2004RXNoNo► Subscribe► Subscribe
Teva Pharms
CAPSULE;ORAL075435-003Oct 8, 2004RXNoNo► Subscribe► Subscribe
TABLET;ORAL075827-002Dec 15, 2004DISCNNoNo► Subscribe► Subscribe
TABLET;ORAL076877-001Jul 6, 2006DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.